Exparel and Education to Avoid Opioids After Carpal Tunnel Release
ConditionCarpal Tunnel Syndrome
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorKettering Health Network
About this trial
This trial seeks to use the long acting local anesthetic Exparel, in conjunction with opioid education, to attempt to avoid any post-operative opioid use following carpal tunnel surgery. This group will be compared with a "standard" group that receives non-liposomal bupivacaine, opioid education, and opioids.
Eligibility criteria
Qualifiers
carpal tunnel syndrome diagnosed either by physical exam or EMG
age >18.
Disqualifiers
allergy to bupivacaine
pre-operative opioid usage within the last six months
patients allergic to Percocet or acetaminophen
patients taking tricyclic antidepressants (interaction with bupivacaine)
Trial design
Treatments tested in this trial
- Differing pain management strategy
Treatment groups
64 Participants
are divided into 2 treatment groupsLocations
2Orthopedic Associates of Southwest Ohio45414, DaytonOhio, United States
Orthopedic Associates of Southwest Ohio45459, DaytonOhio, United States
Sponsors and collaborators
Kettering Health Network
Lead sponsor
American Society for Surgery of the Hand
Collaborator
Source ClinicalTrials.gov